Avera Health Introduces PGx Testing for Pain Meds through Pilot Effort Eyeing Broader Implementation | GenomeWeb

Avera Health, a network of hospitals, clinics, and nursing homes serving South Dakota and surrounding regions, has launched a pilot project to use pharmacogenetic testing to personalize pain medications in orthopedic patients.

After researching the genetic underpinnings of drug response for several years, the Avera Institute for Human Genetics decided in mid-December to begin offering PGx testing for pain medications given the variable responses patients have to such drugs.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.